JPM
JPMorgan Chase & Co.
JPM has the edge over RDN overall, supported by stronger fundamentals and stronger modeled upside.
RDN
Radian Group Inc.
RDN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RDN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
RDN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RDN.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over RDN in the historical PE scenario, which offers more potential upside but is not a forecast.
RDN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $23.35 | -36% |
| Forward | 7.1x | $36.75 | — |
| Fair | 8.1x | $33.18 | -9.7% |
| Current | 9x | $36.75 | — |
| Expensive | 9.2x | $37.34 | +1.6% |
Historical ranges are pointers, not guarantees.
RDN's PE is in its expensive range at 9.0x. If earnings grow as analysts expect, today's price would be 7.1x next year's earnings, in its cheap range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RDN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RDN, but weaker profitability.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over RDN on earnings, with more consistent year-over-year improvement.
RDN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.16 | +26% |
| Q3 2026 | $4.08 | +2% |
| Q2 2026 | $3.89 | -1.8% |
| Q1 2026 | $4.06 | +3.6% |
| Q4 2025 | $4.15 | +5.9% |
| Q3 2025 | $4.00 | +3.9% |
| Q2 2025 | $3.96 | +3.1% |
| Q1 2025 | $3.92 | +4% |
| Q4 2024 | $3.92 | +4% |
RDN earned $4.08 per share over the past year, up 2% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over RDN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RDN on profitability, with a higher operating margin.
RDN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $624.1M | +106% |
| Q2 2026 | $575M | +81% |
| Q1 2026 | $466.3M | +47% |
| Q4 2025 | $300.5M | -4.9% |
| Q3 2025 | $303.2M | -9.2% |
| Q2 2025 | $318M | -1% |
| Q1 2025 | $318.1M | -0.4% |
| Q4 2024 | $315.9M | -3.1% |
RDN's revenue has picked up after three years of holding roughly level: $624M last quarter, up 106% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | -29 points |
| Q2 2026 | 26% | -29 points |
| Q1 2026 | 37% | -22 points |
| Q4 2025 | 67% | +7 points |
| Q3 2025 | 66% | +7 points |
| Q2 2025 | 55% | -3.5 points |
| Q1 2025 | 59% | -2.9 points |
| Q4 2024 | 60% | +4.7 points |
RDN's operating margin was 37% last quarter, down 29 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
RDN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $379M | +6% |
| Q2 2026 | $342.7M | +$1.1B |
| Q1 2026 | $284.3M | +327% |
| Q4 2025 | $406.1M | +$675.9M |
| Q3 2025 | $357.6M | +$595.7M |
| Q2 2025 | -$714.6M | -$506.3M |
| Q1 2025 | $66.6M | +35% |
| Q3 2024 | -$238.1M | -417% |
RDN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over RDN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RDN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -1.9M shares |
| 1 year | -2.6% | -3.5M shares |
| 3 years | -16% | -25.8M shares |
| 5 years | -29% | -53.7M shares |
| Available history | -34% | -70.8M shares |
RDN has 134M diluted shares, down 2.6% from a year ago, with $256M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $125.5M |
| Q2 2026 | $80.3M |
| Q1 2026 | $50M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $223M |
| Q1 2025 | $208.9M |
| Q4 2024 | $76M |
RDN spent $256M buying back its own shares over the past year, down 50% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
RDN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q4 2019 | 0.9x | Very low |
RDN's net debt is about 1.3 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like RDN.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RDN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.5 | Neutral |
| Stochastic | 60.6 | Neutral |
RDN's weekly RSI is 55 (neutral) and its Stochastic is 61 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
RDN PE vs Financial Services Sector
| Metric | RDN | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 79 | 63 | 16 pts above |
RDN has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
RDN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.7 | 5.9% above |
| 20 week MA | $36.2 | 1.4% above |
| 50 week MA | $35.3 | 4.1% above |
| 100 week MA | $34.5 | 6.5% above |
| 200 week MA | $31.6 | 16% above |
RDN has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over RDN on returns for 2026, with the stronger performance.
RDN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.3 | $20.0 | -21% |
| 2021 | $20.0 | $20.5 | +2.6% |
| 2022 | $20.5 | $19.1 | -7.1% |
| 2023 | $19.1 | $28.6 | +50% |
| 2024 | $28.6 | $31.8 | +11% |
| 2025 | $31.8 | $36.4 | +15% |
| 2026 YTD | $36.4 | $36.8 | +0.9% |
RDN has finished higher in four of the last six years. It's up 0.9% so far in 2026.